Tranexamic acid (TXA) may be a useful adjunct for military patients with severe traumatic brain injury\n(TBI). These patients are often treated in austere settings without immediate access to neurosurgical intervention.\nThe purpose of this study was to evaluate any association between TXA use and progression of intracranial\nhemorrhage (ICH), neurologic outcomes, and venous thromboembolism (VTE) in TBI.\nMethods: This was a retrospective cohort study of military casualties from October 2010 to December 2015 who were\ntransferred to a military treatment facility (MTF) in the United States. Data collected included: demographics, types of\ninjuries, initial and interval head computerized tomography (CT) scans, Glasgow Coma Scores (GCS), and six-month\nGlasgow Outcome Scores (GOS). Results were stratified based on TXA administration, progression of ICH, and VTE.............
Loading....